ACLARION, INC. Operating Lease, Expense
ACLARION, INC. (ACON) reported Operating Lease, Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-18
- ACLARION, INC. operating lease, expense for the quarter ending 2025-09-30 was $0.00.
- ACLARION, INC. operating lease, expense for the quarter ending 2025-03-31 was $0.00.
- ACLARION, INC. operating lease, expense for the quarter ending 2024-12-31 was $0.00.
- ACLARION, INC. operating lease, expense for the quarter ending 2024-09-30 was $0.00.
- ACLARION, INC. operating lease, expense for fiscal 2025 was $0.00.
- ACLARION, INC. operating lease, expense for fiscal 2024 was $0.00.
- ACLARION, INC. operating lease, expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ACLARION, INC. operating lease, expense for fiscal 2022 was $36.07K, a 44.45% decline from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 | |||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 derived: sum of 4 quarters · filed 2026-03-18 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-04-09 | $0.00 derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-09 | $0.00 derived: sum of 3 quarters · filed 2025-04-09 | $0.00 derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $0.00 derived: sum of 2 quarters · filed 2025-04-09 | $0.00 derived: sum of 3 quarters · filed 2025-04-09 | $0.00 10-K · filed 2025-04-09 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-25 | $0.00 10-Q · filed 2023-08-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-07-03 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $16.43K derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $16.43K derived: sum of 3 quarters · filed 2024-03-28 | $36.07K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $1.37K 10-Q · filed 2022-11-14 | $16.43K derived: sum of 2 quarters · filed 2023-11-14 | $36.07K 10-Q · filed 2023-11-14 | $33.88K 10-Q · filed 2022-11-14 | $48.74K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $16.43K 10-Q · filed 2023-08-25 | $32.51K 10-Q · filed 2023-08-25 | $48.74K derived: sum of 3 quarters · filed 2023-08-25 | $65.68K derived: sum of 4 quarters · filed 2023-08-25 | ||
| 2022-03-31 | $16.09K 10-Q · filed 2023-07-03 | $32.32K derived: sum of 2 quarters · filed 2023-07-03 | $49.25K derived: sum of 3 quarters · filed 2023-07-03 | |||
| 2021-12-31 | $16.23K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $33.17K derived: sum of 2 quarters · filed 2023-06-12 | $64.93K 10-K/A · filed 2023-06-12 | |||
| 2021-09-30 | $16.93K 10-Q · filed 2022-11-14 | $48.70K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |